Myriad Genetics Inc (MYGN)

R&D Expense Growth

-7.75%

Quarterly · Period ending:

MYGN logo

MYGN R&D Expense Growth

Latest reported-7.75%
MYGN Quarterly R&D Growth (QoQ) (0.00% → -7.75%)
High-resolution chart · PNG

MYGN r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-14.0061%
-9.8667%
6.373%
13.0828%
-6.711%
34.4032%
6.8966%
-1.6949%
-3.2787%
7.0175%
-1.7241%
-7.9365%
14.5455%
10%
-19.3548%
19.2308%
23.8095%
-16%
21.9512%
-2.381%
13.5135%
32.1429%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.